Scientists in India are conducting a 30-day trial to evaluate the safety and effectiveness of a device for treating HIV, hepatitis and other infectious diseases. Aethlon Medical's Hemopurifier is designed to protect the immune system by eliminating the toxic proteins released by HIV and stimulating the growth of CD4 immune cells.

Full Story:
The Hindu (India)

Related Summaries